We found 624 records for "Clinical research"

Articles

A breakthrough in lung cancer - the biggest prize in immunotherapy

31st October 2014

 A breakthrough in lung cancer - the biggest prize in immunotherapyArticles

AstraZeneca/MedImmune hopes its immunotherapy combinations will help it catch up with leaders.The exciting new generation of immuno-oncology drugs, led by Merck's Keytruda and Bristol-Myers Squibb's (BMS) Opdivo have arrived, and...

Read more

Cancer drugs: value is about more than cost

23rd October 2014

 Cancer drugs: value is about more than costArticles

When assessing the true value of cancer drugs, collaboration with key stakeholders, reform of the development process and reimbursement system, and a true understanding of what is important to the...

Read more

Cutting-edge DNA sequencing to speed diagnostics

21st October 2014

 Cutting-edge DNA sequencing to speed diagnosticsArticles

Next Generation Sequencing (NGS) technologies are allowing scientists to sequence DNA faster and expand knowledge of the genetic basis of disease. NGS is showing particular promise in areas where current...

Read more

Patients as partners in medicines development – the EUPATI project

17th October 2014

 Patients as partners in medicines development – the EUPATI projectArticles

As the head of EUPATI, a consortium of organisations working to put patients at the heart of drug R&D, Jan Geissler has seen first-hand how bringing patients and industry together...

Read more

News

Orphan drugs no longer niche

30th October 2014

 Orphan drugs no longer nicheNews

By 2020 orphan drugs are expected to account for 19 per cent of the total share of prescription drug sales in the US, Japan and Europe, excluding generics, reaching $176...

Read more

Pfizer Q3 sound as CEO rules nothing out

29th October 2014

 Pfizer Q3 sound as CEO rules nothing out News

Pfizer's Q3 figures were just above projections, with revenues of $12.36 billion against estimates of $12.3 billion.However, the company has narrowed its full-year guidance from $48.7 billion-$50.7 billion to between...

Read more

AZ's ovarian cancer drug Lynparza recommended in Europe

28th October 2014

 AZ's ovarian cancer drug Lynparza recommended in EuropeNews

A novel PARP inhibitor has received a positive opinion for treating ovarian cancer from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP).The committee has recommended...

Read more

Merck's Keytruda granted breakthrough status in lung cancer

27th October 2014

 Merck's Keytruda granted breakthrough status in lung cancerNews

Merck's newly launched immunotherapy treatment Keytruda has just been granted special fast-track status for use in non-small cell lung cancer (NSCLC).Keytruda (pembrolizumab) is the first of a new generation of PD-1...

Read more

White Papers

Opportunities and challenges around non-adherence and self‑management in diabetes

3rd October 2014

 Opportunities and challenges around non-adherence and self‑management in diabetesWhite Papers

Diabetes is a chronic condition, the prevalence of which has been escalating around the world for years. The significant consequences this has for healthcare budgets and patient wellbeing is well...

Read more

Connected data and the use of smartphone enabled apps in market research

11th July 2014

 Connected data and the use of smartphone enabled apps in market researchWhite Papers

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise...

Read more

Personalised Medicine – the Future of Blockbuster Pharma?

29th October 2013

 Personalised Medicine – the Future of Blockbuster Pharma?White Papers

The personalised medicine approach is rapidly becoming the new norm for pharmaceutical industry drug development and commercialisation, but it demands much more forward-thinking decision-making, as Phenestra outlines in its latest...

Read more

Round table transcript: Oncology shaping the future of personalised healthcare

2nd October 2013

 Round table transcript: Oncology shaping the future of personalised healthcareWhite Papers

Earlier this year pharmaphorum filmed a round table debate exploring how developments in personalised healthcare cancer treatments are defining the future for this area beyond oncology. In this white paper,...

Read more

Audio & Video

Executive Perspectives: Jane Griffiths

  In the latest in our series of interviews with senior executives who are steering the global pharma industry through a period of unparalleled change, pharmaphorum speaks with Jane Griffiths, Company...

Read more

Full round table: Oncology shaping the future of personalised healthcare

  Watch the full round table video debate on 'oncology shaping the future of personalised healthcare', to see what our expert panel, with representation from pharma, diagnostics, physicians and patients, think...

Read more

Events

BioPharma Mexico 2014

4th November 2014 - 5th November 2014

BioPharma Mexico 2014

The 2nd annual BioPharma Mexico conference brings together COFEPRIS, government, payers, biopharma, biotech and academia to talk about strategies to bring biocomparables, stem cells and orphan drugs to market faster....

Read more

9th Generics Asia

4th November 2014 - 7th November 2014

9th Generics Asia

IBC Asia’s Generics Asia conference this 4-7 November 2014 at the Grand Copthorne Waterfront Hotel, Singapore will bring you the current market scenario and how generics companies moving up the...

Read more

Bioequivalence: Intersection Between Science & Regulatory Summit

5th November 2014 - 6th November 2014

Bioequivalence: Intersection Between Science & Regulatory Summit

In today’s high-risk, overcrowded and highly regulated drug development marketplace, we understand the drug development industry is in critical need of innovative approaches and methodologies to achieve bioequivalence in order...

Read more

Partnerships in Clinical Trials

5th November 2014 - 6th November 2014

Partnerships in Clinical Trials

Creators, innovators, storytellers and rising stars will come together at the 13th Annual Partnerships in Clinical Trials Congress, 5-6 November 2014 at the CCIB, Barcelona, Spain to provoke change and...

Read more

Press Releases

Clinical Professionals Group Launches Graduate Training Academy

16th October 2014

Clinical Professionals Group Launches Graduate Training Academy

The Clinical Professionals Group is known for their innovation and added value services to Life Sciences and is delighted to announce the launch of their unique Life Sciences Graduate Academy. With...

Read more

Reality medicine: How payers, regulators and pharma are working with real-world data

23rd September 2014

Reality medicine: How payers, regulators and pharma are working with real-world data

Real-world data (RWD) is creating an entirely new dimension to the evidence base for medicines that will be a critical component in how healthcare dollars are spent. Payers, regulators and...

Read more

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

18th September 2014

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

The latest Gower Pharmaceutical and Healthcare Industry Books Catalogue is now available online! Expanding on the Pharma and Health content this year, we have added details of books from our Governance & Leadership...

Read more

Inspire Community to Surpass Milestone of 500,000 Members

30th June 2014

Inspire Community to Surpass Milestone of 500,000 Members

SAN DIEGO, CA--(Marketwired - Jun 16, 2014) - Inspire, the social network for health, is about to reach the 500,000 member milestone. Inspire CEO Brian Loew announced the news today at...

Read more